Introduction:
South Africa, home to roughly 13% of the global human immunodeficiency virus (HIV) positive population, is battling with financial pressure and consequential cuts to the government's HIV budget. A novel HIV prevention injec...
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management.
You’ll also feel our high-impact global and local perspectives with cultural intelligence.